RNA-based therapeutics
RNA-based Therapeutics and Vaccines Market Expected to Witness - openPR.com
The Future of RNA Therapeutics, From Design to Delivery - Technology Networks
Editorial: Recent advancements in RNA-based and targeted therapeutics - Frontiers
80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - GlobeNewswire
Mechanisms of RNA-based therapeutics that are dependent on the... - ResearchGate
Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA-editing Therapeutics - Eastern Progress
2025 Predictions for RNA Therapeutics - themedicinemaker.com
Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT Gene - Expands Global IP in Precision Oncology Platform - PR Newswire
The year ahead for RNA therapeutic development and manufacturing - European Pharmaceutical Review
RNA Nanotechnology
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors - Nature
RNA Nanotechnology for Codelivering High-Payload Nucleoside Analogs to Cancer with a Synergetic Effect - ACS Publications
RNA-lipid nanoparticle therapeutics for women’s health - Frontiers
Genetic encoding and expression of RNA origami cytoskeletons in synthetic cells - Nature
The secondary and tertiary structures of Mango RNA aptamer. (A) The... - ResearchGate
The body's own courier service for genetic medicines - Eindhoven University of Technology
Untapped power: Logical operations using RNA droplets - Phys.org
Pioneer in RNA nanotechnology named Ohio State Innovator of the Year - Ohio State News
RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics - Frontiers
Structural nucleic acid nanotechnology.(A) Design of a DNA 2D lattice... - ResearchGate
RNA Editing
Lilly Makes $1.3B RNA Editing Bet With Rznomics to Build Out Hearing Loss Pipeline - BioSpace
Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting - GlobeNewswire
A novel adenosine-to-inosine RNA editing-based nomogram for predicting prognosis of hepatocellular carcinoma - Frontiers
Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA-editing Therapeutics - Yahoo Finance
Astrocytic RNA editing regulates the host immune response to alpha-synuclein - Science | AAAS
Lilly inks $1.3 bil. RNA-editing deal with Rznomics to expand hearing loss pipeline - koreabiomed.com
Gene Editing Marches On Despite Missed Beats - Genetic Engineering and Biotechnology News
RNA editing enzyme found to trigger neuroinflammation in Parkinson's - News-Medical
Leveraging genetics to understand ADAR1-mediated RNA editing in health and disease - Nature
RNA Sequencing
Single-cell RNA sequencing reveals immunological link between house dust mite allergy and childhood asthma - Nature
Metabolism-associated marker gene-based predictive model for prognosis, targeted therapy, and immune landscape in ovarian cancer: an integrative analysis of single-cell and bulk RNA sequencing with spatial transcriptomics - BMC Women's Health
Baylor researchers develop and validate clinical diagnostic RNA sequencing test - Baylor College of Medicine | BCM
PbImpute: Precise Zero Discrimination and Balanced Imputation in Single-Cell RNA Sequencing Data - ACS Publications
Author Correction: Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer - Nature
A systematic benchmark of Nanopore long-read RNA sequencing for transcript-level analysis in human cell lines - Nature
Demultiplexing and barcode-specific adaptive sampling for nanopore direct RNA sequencing - Nature
Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma - Nature
Single-nucleus total RNA sequencing of formalin-fixed paraffin-embedded samples using snRandom-seq - Nature
Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer - Nature
